首页> 美国卫生研究院文献>Infection and Immunity >Further characterization of delta aroA delta virG Shigella flexneri 2a strain CVD 1203 as a mucosal Shigella vaccine and as a live-vector vaccine for delivering antigens of enterotoxigenic Escherichia coli.
【2h】

Further characterization of delta aroA delta virG Shigella flexneri 2a strain CVD 1203 as a mucosal Shigella vaccine and as a live-vector vaccine for delivering antigens of enterotoxigenic Escherichia coli.

机译:δaroAδvirG弗氏志贺氏菌2a菌株CVD 1203的进一步表征为粘膜志贺氏菌疫苗和活载体疫苗用于递送产肠毒素的大肠杆菌抗原。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。
获取外文期刊封面目录资料

摘要

The use of attenuated delta aroA delta virG Shigella flexneri 2a strain CVD 1203 as a live vector for enterotoxigenic Escherichia coli (ETEC) antigens is reported. CVD 1203 alone or expressing colonization factor antigen fimbriae and CS3 fibrillae of ETEC was given to guinea pigs and mice, orogastrically (o.g.) or intranasally (i.n.). CVD 1203 given i.n. elicited high titers of antilipopolysaccharide (anti-LPS) immunoglobulin A (IgA) and was protective in guinea pigs against a homologous conjunctival challenge. Whereas a strong IgA response against colonization factor antigen CS3, and Shigella LPS was detected in tears and serum of guinea pigs after o.g. or i.n. immunization, the i.n. route elicited significantly higher antibody titers. A strong serum IgG response was also observed against the ETEC antigens, although no serum anti-LPS IgG response was detected. The immune response in mice followed a pattern similar to that in guinea pigs, and the difference between the responses after o.g. and i.n. administration was even more remarkable.
机译:据报道,使用减毒的ΔroAΔvirG弗氏志贺氏菌2a菌株CVD 1203作为产肠毒素的大肠杆菌(ETEC)抗原的活载体。将单独的CVD 1203或表达ETEC的定殖因子抗原菌毛和ETEC的CS3原纤维经口胃(例如)或鼻内(i.n.)给予豚鼠和小鼠。 CVD 1203给定为i.n.诱导高滴度的抗脂多糖(anti-LPS)免疫球蛋白A(IgA),并且在豚鼠中对同源结膜刺激具有保护作用。然而,在豚鼠的眼泪和血清中,例如在接受抗凝剂后,对定殖因子抗原CS3和志贺氏菌LPS的IgA反应强烈。或i.n.免疫该途径引起明显更高的抗体滴度。尽管未检测到血清抗LPS IgG反应,但也观察到了针对ETEC抗原的强烈血清IgG反应。小鼠的免疫反应遵循与豚鼠相似的模式,不同点是免疫反应后不同。和i.n.管理更加出色。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号